After massive equity awards, Regeneron's top 2 execs collected smaller pay packages in 2022

After massive equity awards, Regeneron's top 2 execs collected smaller pay packages in 2022

Source: 
Fierce Pharma
snippet: 

It’s a sign of the lucrative times in the biopharma industry that the pay for Regeneron’s co-founders and top two executives—Len Schleifer, M.D., Ph.D., and George Yancopoulos, M.D., Ph.D.—seems unusually low.